2Goodwin GM, Anderson I, Arango C, et al. ECNP consensus meeting[J]. Eur Neuropsychopharm, 2008,18(7):5:35-549.
3Tandon R. Antipsychotics in the treatment of schizophrenia:an overview[J].J Clin Psychiatry, 2011,72 (suppl 1) : 4-8.
4Tandon R, Belmaker RH, Gattaz WF, et al. World psychiatric as- sociation pharmacopsychiatry section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia[J]. Schizophr Res, 2008, 100(1/3) : 20-38.
5Tang YL, Gillespie CF, Epstein MP, et al. Gender differences in 542 Chinese inpatients with schizophrenia [J]. Sehizophr Res, 2007, 97(1/3):88-96.
6Esterberg M, Compton M. Family history of psychosis nega- tively impacts age at onset, negative symptoms, and duration of untreated illness and psychosis in first-episode psychosis pa tients[J]. Psychiatry Res, 2012, 197(1/2) :23-28.
7Rosenfield PJ, Kleinhaus K, Opler M, et al. Later paternal age and sex differences in schizophrenia symptoms[J]. Schizo- phr Res, 2010, 116(2/3) :191-195.
8Ardizzone TD, Bradley RJ, Freeman AM, et al. Inhibition of glucose transport in PC12 cells by the atypical antipsychotic drugs risperidone and clozapine, and structural analogs of clozapine[J]. Brain Res, 2001, 923(1/2):82-90.
9Watanabe J, Suzuki Y, Fukui N, et al. Hypoglycemia associ ated with second Generation antipsychotic agents[J]. Int J Neuropsychopharmacol, 2010, 13(1) : 111.
10Hafner H. Gender differences in schizophrenia [J]. Psycho Neuroendoerinol, 2003,28 ( suppl 2 ) : 17-54.
